Jennison Associates LLC Bristol Myers Squibb CO Transaction History

Jennison Associates LLC

$155 Billion
Q2 2024

A detailed history of Jennison Associates LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Jennison Associates LLC holds 815,466 shares of BMY stock, worth $43.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

815,466

Previous 1,065,915 23.5%

Holding current value

$43.4 Million

Previous $57.8 Million 41.41%

% of portfolio

0.02%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$40.25 - $52.99 $10.1 Million - $13.3 Million	-250,449 Reduced 23.5%	815,466 $33.9 Million
Q1 2024 May 02, 2024	SELL	$47.98 - $54.4 $15.7 Million - $17.8 Million	-327,639 Reduced 23.51%	1,065,915 $57.8 Million
Q4 2023 Feb 01, 2024	SELL	$48.48 - $57.85 $115 Million - $137 Million	-2,375,382 Reduced 63.03%	1,393,554 $71.5 Million
Q3 2023 Oct 31, 2023	BUY	$57.89 - $64.73 $41.5 Million - $46.4 Million	716,218 Added 23.46%	3,768,936 $219 Million
Q2 2023 Aug 03, 2023	SELL	$63.71 - $70.74 $11.3 Million - $12.5 Million	-176,823 Reduced 5.48%	3,052,718 $195 Million
Q1 2023 Apr 26, 2023	SELL	$65.71 - $74.53 $10.7 Million - $12.2 Million	-163,385 Reduced 4.82%	3,229,541 $224 Million
Q4 2022 Feb 09, 2023	SELL	$68.48 - $81.09 $32.3 Million - $38.3 Million	-472,264 Reduced 12.22%	3,392,926 $244 Million
Q3 2022 Nov 01, 2022	SELL	$0.13 - $76.84 $29,913 - $17.7 Million	-230,101 Reduced 5.62%	3,865,190 $275 Million
Q2 2022 Aug 02, 2022	SELL	$72.62 - $79.98 $96.5 Million - $106 Million	-1,329,494 Reduced 24.51%	4,095,291 $315 Million
Q1 2022 May 11, 2022	BUY	$61.48 - $73.72 $117 Million - $140 Million	1,904,959 Added 54.12%	5,424,785 $396 Million
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $91.8 Million - $107 Million	1,711,339 Added 94.63%	3,519,826 $219 Million
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $1.62 Million - $1.9 Million	-27,443 Reduced 1.49%	1,808,487 $107 Million
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $21.1 Million - $23 Million	340,428 Added 22.76%	1,835,930 $123 Million
Q1 2021 May 11, 2021	SELL	$59.34 - $66.74 $20.3 Million - $22.9 Million	-342,537 Reduced 18.64%	1,495,502 $94.4 Million
Q4 2020 Feb 05, 2021	BUY	$57.74 - $65.43 $5.61 Million - $6.36 Million	97,164 Added 5.58%	1,838,039 $114 Million
Q3 2020 Nov 04, 2020	BUY	$57.43 - $63.64 $2.51 Million - $2.78 Million	43,711 Added 2.58%	1,740,875 $105 Million
Q2 2020 Aug 06, 2020	BUY	$54.82 - $64.09 $26.5 Million - $31 Million	483,423 Added 39.83%	1,697,164 $99.8 Million
Q1 2020 May 06, 2020	BUY	$46.4 - $67.43 $28.9 Million - $42 Million	622,193 Added 105.18%	1,213,741 $67.7 Million
Q4 2019 Feb 07, 2020	SELL	$49.21 - $64.19 $9.5 Million - $12.4 Million	-193,114 Reduced 24.61%	591,548 $38 Million
Q3 2019 Nov 08, 2019	SELL	$42.77 - $50.71 $5.26 Million - $6.24 Million	-122,998 Reduced 13.55%	784,662 $39.8 Million
Q2 2019 Aug 06, 2019	SELL	$44.62 - $49.34 $521 Million - $576 Million	-11,666,690 Reduced 92.78%	907,660 $0
Q1 2019 May 10, 2019	BUY	$45.12 - $53.8 $64.7 Million - $77.1 Million	1,433,857 Added 12.87%	12,574,350 $600 Million
Q4 2018 Feb 06, 2019	SELL	$48.76 - $63.23 $506 Million - $657 Million	-10,386,066 Reduced 48.25%	11,140,493 $579 Million
Q3 2018 Nov 08, 2018	BUY	$55.19 - $62.25 $225 Million - $254 Million	4,080,245 Added 23.39%	21,526,559 $1.34 Billion
Q2 2018 Aug 02, 2018	SELL	$50.53 - $62.98 $446 Million - $556 Million	-8,827,109 Reduced 33.6%	17,446,314 $965 Million
Q1 2018 Apr 20, 2018	BUY	$59.92 - $68.98 $102 Million - $117 Million	1,699,455 Added 6.92%	26,273,423 $1.66 Billion
Q4 2017 Jan 25, 2018	SELL	$59.94 - $65.35 $137 Million - $149 Million	-2,280,274 Reduced 8.49%	24,573,968 $1.51 Billion
Q3 2017 Nov 03, 2017	BUY	$55.23 - $63.74 $1.48 Billion - $1.71 Billion	26,854,242	26,854,242 $1.71 Billion

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Account

Jennison Associates LLC Bristol Myers Squibb CO Transaction History